Although the potential of urinary WT-1 as a noninvasive biomarker for podocyte injury was demonstrated in active childhood nephrotic syndrome, there was no difference in exosomal WT-1 between FSGS and non-FSGS [161]. Here, WT1 is linked to nephrotic syndrome.